RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |
MARATHON CAPITAL MANAGEMENT | 170,615 | $1,305,205 | 0.33% |
Nikko Asset Management Americas, Inc. | 3,523,124 | $26,951,899 | 0.32% |
Lingotto Investment Management LLP | 775,077 | $5,929,339 | 0.32% |
Values First Advisors, Inc. | 53,065 | $405,945 | 0.26% |
Comprehensive Financial Management LLC | 941,895 | $7,205,497 | 0.26% |
Duquesne Family Office | 906,767 | $6,937 | 0.25% |
Green Alpha Advisors, LLC | 34,542 | $264,246 | 0.20% |
Cercano Management LLC | 685,018 | $5,240,388 | 0.19% |
Baillie Gifford | 24,551,409 | $187,818,279 | 0.17% |
Bienville Capital Management, LLC | 58,053 | $444,105 | 0.12% |
External links
This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q3 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.